Efficacy and Safety of Evogliptin When Added to Ongoing Metformin and Dapagliflozin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control
Clinical trial NCT04170998 · COMPLETED
Trial details
- NCT number
- NCT04170998
- Sponsor
- Dong-A ST Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-02
- Primary completion
- 2021-06-28
- Enrollment
- 283
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.